Neuro Regulatory Mainstay Medical Announces Receipt of FDA Approval for MRI Labeling on ReActiv8® Restorative Neurostimulation System™ byJosh SandbergFebruary 12, 2024
Neuro Spine Mainstay Medical Announces Publication of Two-Year Patient Outcomes Data from ReActiv8-B Clinical Trial Demonstrating Long-Term Efficacy of ReActiv8® Restorative Neurostimulation™ byChris StewartJanuary 6, 2022
Neuro Regulatory Spine Mainstay Medical Announces U.S. FDA Approval of ReActiv8® Neurostimulation System for Chronic Low Back Pain byJosh SandbergJune 22, 2020
Neuro Regulatory Spine SurGenTec® Announces FDA Clearance for Neurostimulation with ALARA™ Access Needle Kit byJosh SandbergAugust 22, 2019
